Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study (Q31004717)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Naoki Minami

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Takuya Yoshino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Minoru Matsuura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Yorimitsu Koshikawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Satoshi Yamada

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Takahiko Toyonaga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Yusuke Honzawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Hiroshi Nakase

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

20 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

BMJ open gastroenterology

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

e000021

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus

27 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Role in calcineurin inhibitors for inflammatory bowel disease in the biologics era: when and how to use.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Life-event stress induced by the Great East Japan Earthquake was associated with relapse in ulcerative colitis but not Crohn's disease: a retrospective cohort study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

The pattern and outcome of acute severe colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Inflammatory bowel disease: clinical aspects and established and evolving therapies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Cytomegalovirus colitis complicating inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Infliximab for induction and maintenance therapy for ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

The mechanism of action of cyclosporin A and FK506

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

21 June 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Response of refractory colitis to intravenous or oral tacrolimus (FK506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Cytomegalovirus infection in patients with ulcerative colitis diagnosed by quantitative real-time PCR analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Management of acute severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJGAST-2014-000021

Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599165

Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies

25 November 2018

1 reference

12 December 2020

Management of acute severe colitis

1 reference

12 December 2020

Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis

1 reference

12 December 2020

Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus

1 reference

12 December 2020

10.1136/BMJGAST-2014-000021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

PubMed publication ID

26462273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462273%20AND%20SRC:MED&resulttype=core&format=json